1. Murai, Junko, Huang, Shar-yin N, Das, Benu Brata, Takeda, Shunichi, Pommier, Yves. . Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. In Cancer research, 72, 5588-99. doi:10.1158/0008-5472.CAN-12-2753. https://pubmed.ncbi.nlm.nih.gov/23118055/
2. Sun, Qizhi, Gatie, Mohamed I, Kelly, Gregory M. 2019. Serum-dependent and -independent regulation of PARP2. In Biochemistry and cell biology = Biochimie et biologie cellulaire, 97, 600-611. doi:10.1139/bcb-2018-0345. https://pubmed.ncbi.nlm.nih.gov/30880404/
3. Maluchenko, Natalya, Saulina, Alexandra, Geraskina, Olga, Feofanov, Alexey, Studitsky, Vasily. 2023. Zinc-dependent Nucleosome Reorganization by PARP2. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.10.17.562808. https://pubmed.ncbi.nlm.nih.gov/37904948/
4. Jankó, Laura, Tóth, Emese, Laczik, Miklós, Bálint, Bálint L, Bai, Péter. 2023. PARP2 poly(ADP-ribosyl)ates nuclear factor erythroid 2-related factor 2 (NRF2) affecting NRF2 subcellular localization. In Scientific reports, 13, 7869. doi:10.1038/s41598-023-35076-w. https://pubmed.ncbi.nlm.nih.gov/37188809/
5. Wang, Li-Min, Wang, Pingyuan, Chen, Xiao-Min, Zhang, Ao, He, Jin-Xue. 2023. Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. In EMBO molecular medicine, 15, e16235. doi:10.15252/emmm.202216235. https://pubmed.ncbi.nlm.nih.gov/36652375/